{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T03:08:15Z","timestamp":1768964895051,"version":"3.49.0"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100010679","name":"Pasteur Institute of Iran","doi-asserted-by":"crossref","award":["910"],"award-info":[{"award-number":["910"]}],"id":[{"id":"10.13039\/501100010679","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Immunology"],"published-print":{"date-parts":[[2018,11]]},"DOI":"10.1016\/j.molimm.2018.10.002","type":"journal-article","created":{"date-parts":[[2018,10,18]],"date-time":"2018-10-18T18:32:34Z","timestamp":1539887554000},"page":"306-311","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Comparison of the protective immunity elicited by a Brucella cocktail protein vaccine (rL7\/L12+rTOmp31+rSOmp2b) in two different adjuvant formulations in BALB\/c mice"],"prefix":"10.1016","volume":"103","author":[{"given":"Maryam","family":"Golshani","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mona","family":"Amani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seyed Davar","family":"Siadat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mehdi","family":"Nejati-Moheimani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amin","family":"Arsang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saeid","family":"Bouzari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.molimm.2018.10.002_bib0005","doi-asserted-by":"crossref","first-page":"2666","DOI":"10.1016\/S0264-410X(00)00498-9","article-title":"Adjuvants designed for veterinary and human vaccines","volume":"19","author":"Aucouturier","year":"2001","journal-title":"Vaccine"},{"key":"10.1016\/j.molimm.2018.10.002_bib0010","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/743509","article-title":"A history of the development of Brucella vaccines","author":"Avila-Calder\u00f3n","year":"2013","journal-title":"Biomed. Res. Int."},{"key":"10.1016\/j.molimm.2018.10.002_bib0015","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1586\/erv.10.174","article-title":"CpG DNA as a vaccine adjuvant","volume":"10","author":"Bode","year":"2011","journal-title":"Expert Rev. Vaccines"},{"key":"10.1016\/j.molimm.2018.10.002_bib0020","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1146\/annurev-animal-021815-111326","article-title":"Brucella Spp. virulence factors and immunity","volume":"4","author":"Byndloss","year":"2016","journal-title":"Annu. Rev. Anim. Biosci."},{"issue":"1997","key":"10.1016\/j.molimm.2018.10.002_bib0025","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1084\/jem.186.10.1621","article-title":"Oligonucleotide adjuvants for T helper 1(Th1)-specific vaccination","volume":"186","author":"Carson","year":"1997","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.molimm.2018.10.002_bib0030","doi-asserted-by":"crossref","first-page":"6537","DOI":"10.1128\/IAI.73.10.6537-6546.2005","article-title":"A DNA vaccine coding for the Brucella outer membrane protein 31 confers protection against B. Melitensis and B. Ovis infection by eliciting a specific cytotoxic response","volume":"73","author":"Cassataro","year":"2005","journal-title":"Infect. Immun."},{"key":"10.1016\/j.molimm.2018.10.002_bib0035","doi-asserted-by":"crossref","first-page":"8079","DOI":"10.1128\/IAI.73.12.8079-8088.2005","article-title":"Vaccination with the recombinant Brucella outer membrane protein 31 or a derived 27-amino-acid synthetic peptide elicits a CD4+ T helper 1 response that protects against Brucella melitensis infection","volume":"73","author":"Cassataro","year":"2007","journal-title":"Infect. Immun."},{"key":"10.1016\/j.molimm.2018.10.002_bib0040","doi-asserted-by":"crossref","first-page":"4437","DOI":"10.1016\/j.vaccine.2007.03.028","article-title":"A recombinant subunit vaccine based on the insertion of 27 amino acids from Omp31 to the N-terminus of BLS induced a similar degree of protection against B. Ovis than Rev.1 vaccination","volume":"25","author":"Cassataro","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.molimm.2018.10.002_bib0045","article-title":"Recent advances in Brucella abortus vaccines","volume":"8","author":"Dorneles","year":"2015","journal-title":"Vet. Res."},{"key":"10.1016\/j.molimm.2018.10.002_bib0050","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1016\/j.ajpath.2015.03.003","article-title":"Pathogenesis and immunobiology of brucellosis review of Brucellae host interactions","volume":"185","author":"Figueiredo","year":"2015","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.molimm.2018.10.002_bib0055","doi-asserted-by":"crossref","first-page":"5532","DOI":"10.1016\/j.vaccine.2015.09.013","article-title":"Simultaneous immunization of mice with Omp31 and TF provides protection against Brucella melitensis infection","volume":"33","author":"Ghasemi","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.molimm.2018.10.002_bib0060","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.molimm.2015.01.009","article-title":"Vaccination with recombinant L7\/L12-Truncated Omp31 protein induces protection against Brucella infection in BALB\/c mice","volume":"65","author":"Golshani","year":"2015","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.molimm.2018.10.002_bib0065","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/j.molimm.2015.04.015","article-title":"Improved immunogenicity and protective efficacy of a divalent DNA vaccine encoding Brucella L7\/L12-truncated Omp31 fusion protein by a DNA priming and protein boosting regimen","volume":"66","author":"Golshani","year":"2015","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.molimm.2018.10.002_bib0070","first-page":"436","article-title":"In silico design, cloning and highlevel expression of the fusion protein encoding L7\/L12 and truncated Omp31Brucella proteins","volume":"10","author":"Golshani","year":"2015","journal-title":"Res. Pharm. Sci."},{"key":"10.1016\/j.molimm.2018.10.002_bib0075","doi-asserted-by":"crossref","first-page":"75","DOI":"10.7774\/cevr.2016.5.1.75","article-title":"In silico analysis of Brucella abortus Omp2b and in vitro expression of SOmp2b","volume":"5","author":"Golshani","year":"2016","journal-title":"Clin. Exp. Vaccine Res."},{"key":"10.1016\/j.molimm.2018.10.002_bib0080","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.vetmic.2016.10.027","article-title":"Comparison of potential protection conferred by three immunization strategies (protein\/protein, DNA\/DNA, and DNA\/protein) against Brucella infection using Omp2b in BALB\/c Mice","volume":"25","author":"Golshani","year":"2016","journal-title":"Vet. Microbiol."},{"key":"10.1016\/j.molimm.2018.10.002_bib0085","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.ijmm.2017.03.004","article-title":"Protein\/protein, DNA\/DNA and DNA\/protein based vaccination strategies using truncated Omp2b against Brucella infection in BALB\/c mice","volume":"307","author":"Golshani","year":"2017","journal-title":"Int. J. Med. Microbiol."},{"key":"10.1016\/j.molimm.2018.10.002_bib0090","doi-asserted-by":"crossref","DOI":"10.1186\/1297-9716-43-29","article-title":"What have we learned from brucellosis in the mouse model?","author":"Grill\u00f3","year":"2012","journal-title":"Vet. Res."},{"key":"10.1016\/j.molimm.2018.10.002_bib0095","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.rvsc.2006.07.014","article-title":"Induction of immune response in mice with a DNA vaccine encoding outer membrane protein (omp31) of Brucella melitensis 16M","volume":"82","author":"Gupta","year":"2007","journal-title":"Res. Vet. Sci."},{"key":"10.1016\/j.molimm.2018.10.002_bib0100","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1016\/j.addr.2013.05.013","article-title":"Particulate formulations for the delivery of poly (I: C) as vaccine adjuvant","volume":"65","author":"Hafner","year":"2013","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.molimm.2018.10.002_bib0105","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1016\/S0264-410X(97)00140-0","article-title":"Nucleic acid vaccination of Brucella abortus ribosomal L7\/L12 gene elicits immune response","volume":"15","author":"Kurar","year":"1997","journal-title":"Vaccine"},{"key":"10.1016\/j.molimm.2018.10.002_bib0110","doi-asserted-by":"crossref","first-page":"281","DOI":"10.4142\/jvs.2017.18.S1.281","article-title":"Development and trial of vaccines against Brucella","volume":"18","author":"Lalsiamthara","year":"2017","journal-title":"J. Vet. Sci."},{"key":"10.1016\/j.molimm.2018.10.002_bib0115","doi-asserted-by":"crossref","first-page":"72","DOI":"10.2174\/1874318801004010072","article-title":"Brucellosis - risk factors and prevalence: a review","volume":"4","author":"Lopes","year":"2010","journal-title":"Open Vet. Sci. J."},{"key":"10.1016\/j.molimm.2018.10.002_bib0120","doi-asserted-by":"crossref","first-page":"2734","DOI":"10.1128\/IAI.74.5.2734-2741.2006","article-title":"Protective immunity elicited by a divalent DNA vaccine encoding both the L7\/L12 and Omp16 genes of Brucella abortus in BALB\/c mice","volume":"74","author":"Luo","year":"2006","journal-title":"Infect. Immun."},{"key":"10.1016\/j.molimm.2018.10.002_bib0125","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1097\/00029330-200602020-00012","article-title":"DNA vaccine encoding L7\/L12-P39 of Brucella abortus induces protective immunity in BALB\/c mice","volume":"119","author":"Luo","year":"2006","journal-title":"Chin. Med. J."},{"key":"10.1016\/j.molimm.2018.10.002_bib0130","first-page":"659","article-title":"Recombinant L7\/L12 ribosomal protein and gamma-irradiated Brucella abortus induce a T-helper 1 subset response from murine CD4+ T cells","volume":"83","author":"Oliveira","year":"1994","journal-title":"Immunology"},{"key":"10.1016\/j.molimm.2018.10.002_bib0135","doi-asserted-by":"crossref","first-page":"102","DOI":"10.2174\/1874318801004010102","article-title":"Recent advances in understanding immunity against brucellosis: application for vaccine development","volume":"4","author":"Oliveira","year":"2010","journal-title":"Open Vet. Sci. J."},{"key":"10.1016\/j.molimm.2018.10.002_bib0140","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/0264-410X(96)00018-7","article-title":"Immunization of mice with recombinant L7\/Ll2 ribosomal protein confers protection against Brucella abortus infection","volume":"14","author":"Olivera","year":"1996","journal-title":"Vaccine"},{"key":"10.1016\/j.molimm.2018.10.002_bib0145","doi-asserted-by":"crossref","first-page":"4857","DOI":"10.1128\/IAI.71.9.4857-4861.2003","article-title":"A DNA vaccine encoding Cu, Zn superoxide dismutase of Brucella abortus induces protective immunity in BALB\/c mice","volume":"71","author":"Onate","year":"2003","journal-title":"Infect. Immun."},{"key":"10.1016\/j.molimm.2018.10.002_bib0150","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1111\/j.1574-6976.2010.00211.x","article-title":"Towards a Brucella vaccine for humans","volume":"34","author":"Perkins","year":"2010","journal-title":"FEMS Microbiol. Rev."},{"key":"10.1016\/j.molimm.2018.10.002_bib0155","doi-asserted-by":"crossref","DOI":"10.1155\/2011\/518323","article-title":"Laboratory animal models for brucellosis research","author":"Silva","year":"2011","journal-title":"J. Biomed. Biotechnol."},{"key":"10.1016\/j.molimm.2018.10.002_bib0160","doi-asserted-by":"crossref","first-page":"137","DOI":"10.20506\/rst.32.1.2190","article-title":"Immunity to brucellosis","volume":"32","author":"Skendros","year":"2013","journal-title":"Rev. Sci. Tech. Off. Int. Epiz."},{"key":"10.1016\/j.molimm.2018.10.002_bib0165","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.molimm.2016.01.001","article-title":"Immunogenicity and protective efficacy of Brucella abortus recombinant protein cocktail (rOmp19+rP39) against B. Abortus 544 and B. Melitensis 16M infection in murine model","volume":"71","author":"Tadepalli","year":"2016","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.molimm.2018.10.002_bib0170","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1586\/erv.11.84","article-title":"Outlining novel cellular adjuvant products for therapeutic vaccines against cancer","volume":"10","author":"Tefit","year":"2011","journal-title":"Expert Rev. Vaccines"},{"issue":"Suppl 6","key":"10.1016\/j.molimm.2018.10.002_bib0175","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1186\/1471-2105-14-S6-S3","article-title":"Meta-analysis of variables affecting mouse protection efficacy of whole organism Brucella vaccines and vaccine candidates","volume":"14","author":"Todd","year":"2013","journal-title":"BMC Bioinformatics"},{"key":"10.1016\/j.molimm.2018.10.002_bib0180","doi-asserted-by":"crossref","first-page":"2574","DOI":"10.1073\/pnas.0711976105","article-title":"The microbial mimic poly IC induces durable and protective CD4+ T cell immunity together with a dendritic cell targeted vaccine","volume":"105","author":"Trumpfheller","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.molimm.2018.10.002_bib0185","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1146\/annurev.iy.06.040188.001343","article-title":"Structure and function of human and murine receptors for IgG","volume":"6","author":"Unkeless","year":"1988","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.molimm.2018.10.002_bib0190","doi-asserted-by":"crossref","first-page":"4271","DOI":"10.1128\/IAI.00761-12","article-title":"Crucial role of gamma interferon-producing CD4+Th1 cells but dispensable function of CD8+ T Cell, B Cell, Th2, and Th17 responses in the control of Brucella melitensis infection in mice","volume":"80","author":"Vitry","year":"2012","journal-title":"Infect. Immun."},{"key":"10.1016\/j.molimm.2018.10.002_bib0195","doi-asserted-by":"crossref","first-page":"7297","DOI":"10.1128\/IAI.73.11.7297-7303.2005","article-title":"Selection of protective epitopes for Brucella melitensis by DNA vaccination","volume":"73","author":"Yang","year":"2005","journal-title":"Infect. Immun."},{"key":"10.1016\/j.molimm.2018.10.002_bib0200","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.molimm.2011.08.009","article-title":"Immunoproteomics analysis of Brucella melitensis and identification of a new immunogenic candidate protein for the development of brucellosis subunit vaccine","volume":"49","author":"Yang","year":"2011","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.molimm.2018.10.002_bib0205","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1007\/s11515-012-1196-0","article-title":"Progress in Brucella vaccine development","volume":"8","author":"Yang","year":"2013","journal-title":"Front. Biol. (Beijing)"}],"container-title":["Molecular Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161589018304978?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161589018304978?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,10,27]],"date-time":"2019-10-27T01:20:48Z","timestamp":1572139248000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0161589018304978"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11]]},"references-count":41,"alternative-id":["S0161589018304978"],"URL":"https:\/\/doi.org\/10.1016\/j.molimm.2018.10.002","relation":{},"ISSN":["0161-5890"],"issn-type":[{"value":"0161-5890","type":"print"}],"subject":[],"published":{"date-parts":[[2018,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparison of the protective immunity elicited by a Brucella cocktail protein vaccine (rL7\/L12+rTOmp31+rSOmp2b) in two different adjuvant formulations in BALB\/c mice","name":"articletitle","label":"Article Title"},{"value":"Molecular Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.molimm.2018.10.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}